FLASCO: FLASCO: The Voice of Oncology in FloridaThe Voice of Oncology in Florida

FLASCOFLASCO

20162016––20172017 Board of DirectorsBoard of Directors

YOU, your Colleagues, and All Oncology Healthcare Professionals

are Invited to Attend the

FLASCO 2016 FALL SESSION November 4-5, 2016

Orlando World Center Marriott 8701 World Center Drive │ Orlando, Florida 32821

This conference is

proudly

co-sponsored by

the following

Companies:

Multi-

Disciplinary Pharmacy Nursing

Nurse

Navigator

See Enclosed Agenda for More Details

K ey Note Speaker: Diana Jordan

Healthcare & Wellness Speaker & Humorist

The Healing Power of Laughter

Michael Diaz MD

President

Barry Berman MD

Vice President

Hank Hill MD

Secretary

Richard McDonough MD

Treasurer

Alan Marks MD

Immediate Past President

Kamran Ahmed MD Sikander Ailawadhi MD

Susmitha Apuri MD Gary Bowers MD

Delmarie Butler RN Robert Cassell MD PhD

Chakra Chaulagain MD FACP Alan Collin MD

Gerardo Colon-Otero MD Jose Davila, MD

Craig Deligdish MD Bhagirathbhai Dholaria MBBS Dina Dumercy PharmD BCOP

Ana Espinosa DNP MBA RN OCN Steven Fein MD

Rui Fernandes MD DMD Karen Fields MD

Laura Freedman MD Jorge J. Garcia PharmD

Thomas George MD FACP Shelly Glenn

Lucio Gordan MD Joanna Grabska MD Terry Gruchow PAC Ardeshir Hakam MD William Harrer MD

Eric Harris DO William Harwin MD

Randal Henderson MD MBA John Hiemenz MD Maen Hussein MD

Mohammad Jahanzeb MD Kun Jiang MD

Waseem Khan MD Jeanelle King PA-C

Kapisthalam Kumar MD Richard Levine MD

Mayra Lima MSN ARNP FNP-C Loretta Loftus MD MBA

Shannon Luker RN OCN CBCN Merry-Jennifer Markham MD

Thomas Marsland MD Shahla Masood MD Tarek Mekhail MD

Joseph Mignone MD Daniel Morris MD Sonia Orcutt MD

Pareshkumar Patel MD Vivek Patel MD

Brendan Prendergast MD Luis Raez MD

Edgardo Santos MD Jason Starr DO

Winston Tan MD Scott Tetreault MD

Tabitha Townsend MD Teri Valls

Gene Wetzstein PharmD BCOP Jonathan Zager, MD

Dorothy Phillips Executive Director

C ourse Description: The Florida Society of Clinical Oncology is hosting a two day meeting designed for medical oncologists, hematologists,

radiation oncologists, surgical oncology, pathologists, oncology nurses, nurse practitioners, pharmacists, physician assistants, residents, and fellows that manage heath care for cancer patients. This conference will provide an emphasis on multidisciplinary collaboration among all professional health care teams with

dynamic educational tracks that focus on specific driven topics addressing the current and future changes in the landscape of cancer care.

The 2016 Fall meeting will center on the multi-disciplinary presentations and case studies in lung and melanoma which include the collaboration of top clinicians, as well as up-to-date information on liquid biopsies and information about wellness and healing. Additional sessions include information on hot topics in nursing, patient navigation, and pharmacy.

Diana will discuss how to apply the benefits of stress coping

mechanisms into your practice, with your staff and patients, and

how to educate your cancer patients and their families on how to

integrate beneficial methods to cope with stress and change.

FLASCO Fall Session Features

Four Educational Tracks

Friday, November 4, 2015

6:00pm–7:30pm Reception/Visit Exhibits Cash Bar Available

7:30pm–9:30pm

DINNER & PROGRAM

Welcome & Opening Remarks Michael Diaz, MD, Florida Cancer Specialists │ FLASCO President

Keynote Speaker: Diana Jordan, Healthcare & Wellness Speaker & Humorist The Healing Power of Laughter

Saturday, November 5, 2015

7:00am–8:00am Registration/Breakfast/Visit Exhibitors

8:00am–8:30am Opening Remarks & Supporter Recognition

Luis Raez, MD, FACP, FCCP, Memorial Cancer Institute │ FLASCO Fall Session Conference Chairman

8:30am–9:30am

General Session

Moderator: Luis Raez, MD, Memorial Cancer Institute │ FLASCO Program Chairman

Companion Diagnostics: Unlocking the door to better market access?

9:30am–10:15am Break/Visit Exhibitors

10:15am–11:45am

Multi-Disciplinary Pharmacy Nursing Navigator

MELANOMA Moderator:

Eric Harris, DO Florida Cancer Specialists

Medical: Jose Lutzky, MD Mount Sinai Medical Center

Surgical: Jonathan Zager, MD Moffitt Cancer Center

Radiation: Nikhil G. Rao, MD Florida Hospital

Pathology: Jane Messina, MD Moffitt Cancer Center

Case Study: Tabitha Townsend, MD University of Florida

WELCOME Jorge Garcia, PharmD, MS, MBA, MHA

Memorial Healthcare System

Moderator: Gene Wetzstein, PharmD, BCOP, C.Ph.

ANTIMICROBIAL STEWARDSHIP IN ONCOLOGY CARE

Aliyah Baluch, MD, MSc, FACP University of South Florida Morsani College of Medicine

Rod Quilitz, PharmD, BCOP Moffitt Cancer Center

WELCOME Ana Espinosa, DNP, MBA, RN, OCN

Memorial Cancer Institute

CANCER GENETICS, GENOMICS, AND PHARMACOGENETICS

Moderator: Mayra Lima, MSN, ARNP, FNP-C University of Miami

Jeff Weitzel, MD City of Hope California

Kathleen Blazer, EdD, MS, LCGC City of Hope California

WELCOME Shannon Luker, RN, OCN,

CBCN, CN-BN Parrish Medical Center

Moderator: Del Butler, RN, CBHN, BSHSA, CN-BN

METRICS IN NAVIGATION Sharon Gentry, RN, MSN,

CBCN, CBEC Novant Health: Derrick L Davis Cancer Center

CHALLENGES IN MANAGING CANCER PAIN

David Craig, PharmD, BCPS Moffitt Cancer Center

Dina Dumercy, PharmD, BCPS, BCOP Memorial Healthcare System

Anay Moscu, PharmD, BCPS, BCOP Baptist Health of Miami

EMERGING IMMUNE ONCOLOGY THERAPY

Moderator: Cheryl Habaue, MSN, RN, CCRP Memorial Healthcare System

Keith Knutson, PhD

Mayo Clinic

PSYCHOSOCIAL DISTRESS RESOURCES

Carrie Tompkins Stricker, PhD, RN AOCN Carevive Systems, Inc.

11:45am–1:15pm

LUNCH & PROGRAM Lunch & Program

Moderator: Luis Raez, MD Memorial Cancer Institute

The IASLC Lung Cancer Staging Project: The Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer

Anatomic & Clinical Pathology: Neil A. Abrahams, MD Memorial Healthcare Systems

Moderator: Del Butler, RN, CBHN, BSHSA, CN-BN

Lillie Shockney, RN, BS, MAS Johns Hopkins University School of Medicine

1:30pm–3:00pm

*Nurse Navigator Track will Adjourn

at 4:00pm

Multi-Disciplinary Pharmacy Nursing Navigator*

LUNG CANCER Moderator:

Edgardo Santos, MD Lynn Cancer Institute

Medical Oncology: Tarek Mekhail, MD, MSc, FRCSI, FRCSEd Florida Hospital

Surgical: Luis Herrera, MD Orlando Health

Radiation: Brad Hoppe, MD, MPH University of Florida

Case Study: Shefali Gajjar, MD University of Miami

SPECIALTY PHARMACY & ORAL CHEMOTHERAPIES

Moderator: Melody Chang, PharmD, BCOP, MBA Florida Cancer Specialists

Ray Bailey, RPh Florida Cancer Specialists

Jorge Garcia, PharmD, MS, MBA, MHA Memorial Healthcare System

SUVIVORSHIP MODELS

Moderator: Christa Roe, MA, BS, RN, OCN Moffitt Cancer Center

Lisa Kennedy Sheldon, PhD, ARNP-BC, AOCNP Oncology Nursing Society

PANEL on SURVIVORSHIP

Moderator: Ana Espinosa, DNP, MBA, RN, OCN Memorial Cancer Institute

Danielle Finch, ARNP Mayo Clinic

Cynthia Frankel, RN, OCN, CBCN University of Miami

Maray Salina, ARNP Memorial Healthcare System

Smitha R. Pabbathi, MD Moffitt Cancer Center

Beth Wittmer, RN OCN Florida Cancer Specialists

NAVIGATING PATIENTS TO CLINICAL TRIALS

Moderator: Katie Zacher, MSN

Cameron Richardson, RN, BSN, OCN Florida Hospital

HEREDITARY CANCER TESTING:

THE GAME HAS CHANGED

Moderator: Del Butler, RN, CBHN, BSHSA, CN-BN

Jessica McAfee ARNP MSN BC-FNP Bethesda Women’s Health Canter

BIOSIMILARS

Moderator: Gene Wetzstein, PharmD, BCOP, C.Ph.

Overview & Regulations Philip Johnson, MS, BS Pharm,

FASHP Premier Inc.

Clinical/Formulary Consideration and Implementation

Mandy Leonard, PharmD, BCPS Cleveland Clinic

EMERGING IMMUNE ONCOLOGY & ACCESS

Moderator: Lee Ann Biafora, RN, MSN, ONN Beacon Oncology Nurse Advocates

Keith Knutson, PhD Mayo clinic

PANEL on ACCESS Katie Zacher, MSN

Florida Hospital Don Champlain, RN MHA Florida Cancer Specialists

DNA & free mRNA in plasma for diagnosis & monitoring

Tarek Mekhail, MD, MD, MSc, FRCSI, FRCSEd

Florida Hospital

Circulating tumor cells (CTC) and exosomes

Jhanelle Gray, MD

Moffitt Cancer Center

The role of NGS in blood Edgardo Santos, MD, FACP

Lynn Cancer Institute

Upon completion of the conference you will be able to:

1) The audience will learn how new diagnostic technologies can be applied in treatment decision of

new and recurrent patients with lung cancer

2) To learn liquid biopsy methods like: free DNA, circulating tumor cells and next generation

sequencing in plasma

3) To learn advantages and disadvantages of the implementation of liquid biopsies in Lung Cancer

4) Apply the benefits of stress coping mechanisms into your practice, with your staff and patients.

5) Educate your cancer patients and their families on how to integrate beneficial methods to cope

with stress and change.

6) Understanding the importance of integrative medicine modalities in your practice to expand the

health and well being of the patient.

CONFERENCE OBJECTIVES

Page 3 of 4Page 3 of 4 FLASCO CONFERENCE GOAL FLASCO CONFERENCE GOAL is to continue to develop a comprehensive

range of programs that emphasize the latest developments, state-of-the-art information

and enhanced educational strategies for the intra-professional team.

CONFERENCE OUTCOME MEASURES:CONFERENCE OUTCOME MEASURES:

Participants should be able to apply the knowledge acquired during this Participants should be able to apply the knowledge acquired during this

conference to improve their competence, performance, and/or patient outcomes conference to improve their competence, performance, and/or patient outcomes

in the daily treatment of their patients. To measure attendees perceptions of in the daily treatment of their patients. To measure attendees perceptions of

these gains, they will complete an evaluation form at the end of the conference.these gains, they will complete an evaluation form at the end of the conference.

ACCREDITATION STATEMENTS Physicians: The Medical Educator Consortium is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Medical Educator Consortium designates this live activity for a maximum of TBD AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The Medical Educator Consortium and Florida Society of Clinical Oncology. The Medical Educator Consortium is accredited by the ACCME to provide continuing medical education for physicians.

Disclosure Statement: The Medical Educator Consortium (MEC) adheres to the ACCME Standards for Commercial Support. All persons that will be in a position to control the content of the CME Activity are required to disclose all relevant financial relationships. Faculty disclosure forms outlining this information will be made available to all participants prior to educational activity. MEC has also implemented a mechanism to identify and resolve all conflicts of interest prior to the education activity being delivered to learners. The source of all support from commercial interests will also be disclosed to learners prior to the beginning of the educational activity.

Nurses: Approval for nurses has been applied for with the Southern Florida Chapter of The Leukemia & Lymphoma Society under provider number 50-12996, to award up to TBD continuing education contact hours through the Florida Board of Nursing. FLASCO maintains responsibility for this program.

Pharmacists: Memorial Hospital designates this live activity for a maximum of TBD continuing education credits. FLASCO maintains responsibility for this program.

Nurse Navigator: Approval for nurses has been applied for with the Southern Florida Chapter of The Leukemia & Lymphoma Society under provider number 50-12996, to award up to TBD continuing education contact hours through the Florida Board of Nursing. FLASCO maintains responsibility for this program.

FLASCO acknowledges the following companies as

FLASCO Corporate Members

Diamond Alexion

Amgen

Astellas Pharma

Bayer Oncology

Bristol-Myers Squibb

Celgene

Genentech BioOncology

Heron Therapeutics, Inc

Hospira

Lilly Oncology

Merck

Novartis Oncology

Pfizer Oncology

Sandoz, Inc.

Takeda Oncology

Teva Oncology

Platinum AbbVie

AstraZeneca

Biodesix

bioTheranostics, Inc

Boehringer Ingelheim

Eisai, Inc

Foundation Medicine

Gilead Sciences, Inc

Infinity Pharmaceuticals, Inc.

Insys Therapeutics

Janssen, a Pharmaceutical

Company of J&J

Medivation Field Solutions

Myriad Genetics

NanoString Technologies

Oncology Supply/ION Solutions

Paradigm

Pharmacyclics

Sanofi

Seattle Genetics

Taiho Oncology, Inc.

Walgreens

Gold

Clovis Oncology, Inc.

Exelixis, Inc.

Incyte Corporate

Merrimack Pharmaceuticals

Silver Helsinn

IPSEN BioPharmaceuticals

Spectrum Pharmaceuticals

Sysmex

TESARO

2016 Corporate Members

As of 5/10/2016

Page 4 of 4Page 4 of 4

Before or on October 24,2016 After October 24, 2016

FLASCO Regular Members Complimentary $50.00

FLASCO Affiliate Members Complimentary $50.00

FLASCO Associate Members Complimentary $50.00

FLASCO Courtesy Members $200.00 $250.00

Non-FLASCO Members $250.00 $300.00

Registration is complimentary prior to October 24, 2016 for FLASCO Regular, Affiliate and Associate Members.

Reminder: To keep your complimentary membership active and in good standing, FLASCO members are encouraged to participate in at least one FLASCO event prior to December 31, 2016, or make a minimum contribution of $50 to the FLASCO Foundation, Inc.

FLORIDA SOCIETY OF CLINICAL ONCOLOGY 10022 Water Works Lane │ Riverview, FL │ 33578 Phone: 813.677.0246 ext. 102 │ Fax: 813.677.0559

Email: Dorothy.Green@FLASCO.org

FLASCO reserves the right to alter this program without prior notice. Speakers and agenda are subject to change.

A block of rooms has been reserved at the

Marriott Orlando World Center Hotel

8701 World Center Drive

Orlando, Florida 32821-6358

Reservations can be made by calling (888) 789-3090 or

on line: https://resweb.passkey.com/go/1031

DEADLINES - The Marriott Orlando World Center Hotel has requested that all

reservations be made prior to September 26, 2016. After that date, reservations

will only be accepted on a space available and rate available basis.

HOTEL RESERVATIONS

The Florida Society of Clinical Oncology is a statewide

non-profit organization committed to facilitating and promoting multidisciplinary

efforts to improve patient care in Florida by:

Fostering access to quality cancer care to the citizens of Florida.

Assisting the cancer practitioners in providing the most cost effective quality care for their

patients.

Acting as an advocate for Florida cancer patients and their families.

Coordinating the dissemination of information and providing an opportunity for oncologists,

physicians, and other health care professionals to network and exchange information on cancer

care.

REGISTRATION & FEESREGISTRATION & FEES

FLASCO MISSION STATEMENT